West Pharmaceutical Services Profit Margin 2006-2018 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of December 31, 2018 is 12.05%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $7.847B $1.717B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.612B 22.12
McKesson (MCK) United States $23.502B 9.15
Align Technology (ALGN) United States $20.740B 52.81
AmerisourceBergen (ABC) United States $17.113B 12.41
Laboratory Of America Holdings (LH) United States $15.378B 14.15
Cardinal Health (CAH) United States $15.065B 10.15
Cooper (COO) United States $14.545B 25.37
DENTSPLY SIRONA (XRAY) United States $11.005B 24.60
Henry Schein (HSIC) United States $9.160B 14.61
Merit Medical Systems (MMSI) United States $3.277B 35.31
CONMED (CNMD) United States $2.251B 36.68
Patterson (PDCO) United States $2.145B 16.95
STAAR Surgical (STAA) United States $1.642B 137.56
Atrion (ATRI) United States $1.529B 44.87
Antares Pharma (ATRS) United States $0.547B 0.00
Invacare (IVC) United States $0.300B 0.00
Lifevantage (LFVN) United States $0.206B 27.67
Endologix (ELGX) United States $0.074B 0.00
Pro-Dex (PDEX) United States $0.058B 26.51
Biolase (BIOL) United States $0.051B 0.00
Retractable Technologies (RVP) United States $0.028B 0.00
Milestone Scientific (MLSS) United States $0.014B 0.00
Aceto (ACET) United States $0.006B 0.00